Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccines: ethical framework concerning human challenge studies
Daniela Călina, Thomas Härtung, Anca Oana Docea, et al.
DARU Journal of Pharmaceutical Sciences (2020) Vol. 28, Iss. 2, pp. 807-812
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Masaki Machida, Itaru Nakamura, Takako Kojima, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 210-210
Open Access | Times Cited: 277
COVID-19 pandemic and alcohol consumption: Impacts and interconnections
Daniela Călina, Thomas Härtung, Ileana Mardare, et al.
Toxicology Reports (2021) Vol. 8, pp. 529-535
Open Access | Times Cited: 143
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
Daniela Călina, Chandan Kumar Sarkar, Andreea Letiția Arsene, et al.
Immunologic Research (2020) Vol. 68, Iss. 6, pp. 315-324
Open Access | Times Cited: 70
Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis
Divya Jain, Priya Chaudhary, Nidhi Varshney, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 68
COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer
Yamin Chen, Luying Cheng, Rongna Lian, et al.
BioScience Trends (2021) Vol. 15, Iss. 2, pp. 64-73
Open Access | Times Cited: 63
Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles
Javad Sharifi‐Rad, Jesús Herrera‐Bravo, Prabhakar Semwal, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 43
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation
Muhammad Javed Iqbal, Zeeshan Javed, Jesús Herrera‐Bravo, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 41
Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action
Javad Sharifi‐Rad, Senem Kamiloğlu, Balakyz Yeskaliyeva, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 65
[Comment] COVID‑19 vaccine safety
Ronald N. Kostoff, Michael B. Briggs, Alan L. Porter, et al.
International Journal of Molecular Medicine (2020)
Open Access | Times Cited: 63
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
Ronald N. Kostoff, Darja Kanduc, Alan L. Porter, et al.
Toxicology Reports (2020) Vol. 7, pp. 1448-1458
Open Access | Times Cited: 59
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis, et al.
Toxicology Reports (2020) Vol. 8, pp. 73-83
Open Access | Times Cited: 59
Suicidality and COVID‑19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID‑19 pandemic (Review)
Vasiliki Efstathiou, Maria‐Ioanna Stefanou, Nikolaos Siafakas, et al.
Experimental and Therapeutic Medicine (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Back to basics in COVID‐19: Antigens and antibodies—Completing the puzzle
Monica Neagu, Daniela Călina, Anca Oana Docea, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 10, pp. 4523-4533
Open Access | Times Cited: 45
<p>Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan</p>
Rana Abu Farha, Karem H. Alzoubi, Omar F. Khabour
Patient Preference and Adherence (2020) Vol. Volume 14, pp. 2451-2458
Open Access | Times Cited: 44
The bumpy road to achieve herd immunity in COVID-19
Monica Neagu
Journal of Immunoassay and Immunochemistry (2020) Vol. 41, Iss. 6, pp. 928-945
Open Access | Times Cited: 41
RETRACTED: Why are we vaccinating children against COVID-19?
Ronald N. Kostoff, Daniela Călina, Darja Kanduc, et al.
Toxicology Reports (2021) Vol. 8, pp. 1665-1684
Open Access | Times Cited: 35
Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines
Jasmine Shimin Koh, Rebecca Hui Min Hoe, Ming Hui Yong, et al.
Journal of the Neurological Sciences (2021) Vol. 430, pp. 120030-120030
Open Access | Times Cited: 34
Unraveling the roles of vitamin D status and melanin during Covid‑19 (Review)
Polytimi Sidiropoulou, Anca Oana Docea, Vasiliki Nikolaou, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 92-100
Open Access | Times Cited: 32
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
Riccardo Scotto, Biagio Pinchera, Francesco Perna, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 2078-2078
Open Access | Times Cited: 31
COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Periklis Katopodis, Rachel Kerslake, Julie Davies, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 4
Open Access | Times Cited: 31
Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2
Daniela Călina, Antonio F. Hernández, Thomas Härtung, et al.
Life (2021) Vol. 11, Iss. 9, pp. 907-907
Open Access | Times Cited: 30
Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
Masaki Machida, Hiroyuki Kikuchi, Takako Kojima, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 19
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Ethical considerations of the vaccine development process and vaccination: a scoping review
Habib Jalilian, Mahdi Amraei, Elnaz Javanshir, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top